An accompanying Comment article notes that this study is still held back by difficulties in defining the disease and response criteria. Likewise, there is no validated method to establish response to treatment. It is hoped that the encouraging findings of this study will galvanise researchers to establish validated diagnostic and response criteria for idiopathic multicentric Castleman’s disease. One of the benefits of this study is the establishment of the Castleman Disease Collaborative Network comprising clinicians and researchers and patients.